Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleINFLAMMATION AND IMMUNOPHARMACOLOGY

Antisense Oligonucleotide Blockade of Tumor Necrosis Factor-α in Two Murine Models of Colitis

Kathleen J. Myers, Sreekant Murthy, Anne Flanigan, Donna R. Witchell, Madeline Butler, Susan Murray, Andrew Siwkowski, Deborah Goodfellow, Karen Madsen and Brenda Baker
Journal of Pharmacology and Experimental Therapeutics January 2003, 304 (1) 411-424; DOI: https://doi.org/10.1124/jpet.102.040329
Kathleen J. Myers
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sreekant Murthy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anne Flanigan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Donna R. Witchell
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Madeline Butler
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Susan Murray
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrew Siwkowski
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Deborah Goodfellow
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karen Madsen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brenda Baker
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 304 no. 1 411-424
DOI 
https://doi.org/10.1124/jpet.102.040329
PubMed 
12490618

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0022-3565
Online ISSN 
1521-0103
History 
  • Received July 2, 2002
  • Accepted August 29, 2002
  • Published online January 1, 2003.

Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Kathleen J. Myers1,
  2. Sreekant Murthy2,
  3. Anne Flanigan2,
  4. Donna R. Witchell1,
  5. Madeline Butler1,
  6. Susan Murray1,
  7. Andrew Siwkowski1,
  8. Deborah Goodfellow1,
  9. Karen Madsen3 and
  10. Brenda Baker1
  1. 1Isis Pharmaceuticals, Carlsbad, California (K.J.M., D.R.W., M.B., Su.M., A.S., D.G., B.B.); 2MCP Hahnemann University, Philadelphia, Pennsylvania (Sr.M., A.F.); and 3University of Alberta, Edmonton, Alberta, Canada (K.M.)
  1. Dr. Kathleen J. Myers, Program Leader, Exploratory Research, Isis Pharmaceuticals, 2292 Faraday Ave., Carlsbad, CA 92008. E-mail: kmyers{at}isisph.com
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: December 2002 to May 2022

AbstractFullPdf
Dec 2002384240
Jan 200326122133
Feb 20031013174
Mar 200397662
Apr 200339260
May 200344929
Jun 200335242
Jul 2003154217
Aug 2003103126
Sep 2003124627
Oct 2003195332
Nov 2003123410
Dec 200363533
Jan 2004134538
Feb 2004113113
Mar 2004144830
Apr 2004184727
May 2004437449
Jun 2004428334
Jul 2004459135
Aug 2004439640
Sep 2004235326
Oct 2004144731
Nov 2004104517
Dec 2004123219
Jan 2005167030
Feb 200594830
Mar 2005144127
Apr 200502111
May 200545231
Jun 200544226
Jul 200583814
Aug 200553619
Sep 200532716
Oct 200572922
Nov 200593716
Dec 200562916
Jan 200654225
Feb 20065317
Mar 200622317
Apr 20064127
May 200642715
Jun 200643219
Jul 200621614
Aug 200641910
Sep 200632418
Oct 2006102123
Nov 200622215
Dec 200632514
Jan 200723015
Feb 20075187
Mar 20072217
Apr 200772815
May 200732416
Jun 20076165
Jul 20071168
Aug 200721513
Sep 200752515
Oct 200732219
Nov 200792190
Dec 20072116
Jan 200851214
Feb 2008112419
Mar 20083578
Apr 20087175
May 2008142218
Jun 200882412
Jul 2008372419
Aug 200841245
Sep 200842148
Oct 200826159
Nov 200813158
Dec 20082159
Jan 20094149
Feb 200941711
Mar 2009211310
Apr 200951011
May 200991819
Jun 200952012
Jul 20099102
Aug 20093117
Sep 20091094
Oct 200918109
Nov 20098126
Dec 20091375
Jan 201011511
Feb 201071712
Mar 2010773
Apr 2010584
May 201051412
Jun 201010127
Jul 2010896
Aug 2010056
Sep 2010599
Oct 201031812
Nov 20107169
Dec 20105117
Jan 2011955
Feb 2011876
Mar 2011599
Apr 2011647
May 2011121813
Jun 20118118
Jul 2011121115
Aug 2011111124
Sep 20117816
Oct 2011191823
Nov 2011101211
Dec 201141916
Jan 201261013
Feb 2012101715
Mar 2012161616
Apr 2012151111
May 2012181311
Jun 20127717
Jul 2012789
Aug 201291215
Sep 2012111816
Oct 2012151124
Nov 2012141118
Dec 2012191217
Jan 201381214
Feb 201312515
Mar 2013697
Apr 201361519
May 20135612
Jun 201391115
Jul 20136813
Aug 2013315
Sep 2013667
Oct 20131646
Nov 20136817
Dec 2013494
Jan 201419614
Feb 2014349
Mar 2014758
Apr 20141869
May 20145412
Jun 201410515
Jul 201418811
Aug 2014765
Sep 201471212
Oct 2014552
Nov 20141254
Dec 20141077
Jan 2015235
Feb 20156513
Mar 20153118
Apr 20153137
May 201551212
Jun 201551328
Jul 20156311
Aug 201541112
Sep 201511913
Oct 20154449
Nov 201510144
Dec 2015945
Jan 201611911
Feb 20161145
Mar 20165514
Apr 2016668
May 2016469
Jun 2016101520
Jul 20164717
Aug 20162220
Sep 20163512
Oct 201641111
Nov 2016083
Dec 201621611
Jan 20170177
Feb 20172156
Mar 201701316
Apr 20171145
May 201761010
Jun 20172135
Jul 20173155
Aug 20172166
Sep 201711319
Oct 201712222
Nov 201713217
Dec 201722515
Jan 20180138
Feb 20182259
Mar 20180158
Apr 201801619
May 20180204
Jun 201831314
Jul 2018095
Aug 20181810
Sep 2018093
Oct 2018098
Nov 20180710
Dec 2018554
Jan 2019911
Feb 20191521
Mar 20191500
Apr 20197421
May 2019900
Jun 2019302
Jul 20192000
Aug 20191743
Sep 20191621
Oct 20191903
Nov 20192311
Dec 20192000
Jan 2020900
Feb 2020411
Mar 20202902
Apr 20201900
May 20203233
Jun 20202421
Jul 2020910
Aug 2020400
Sep 20201300
Oct 20202033
Nov 20201500
Dec 20203320
Jan 20212261
Feb 20213122
Mar 20212362
Apr 20211951
May 2021821
Jun 20212033
Jul 20211210
Aug 20211633
Sep 20211120
Oct 20211411
Nov 20212846
Dec 20212710
Jan 20222051
Feb 20221810
Mar 20221452
Apr 20227741
May 2022200

PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics: 304 (1)
Journal of Pharmacology and Experimental Therapeutics
Vol. 304, Issue 1
1 Jan 2003
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Antisense Oligonucleotide Blockade of Tumor Necrosis Factor-α in Two Murine Models of Colitis
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleINFLAMMATION AND IMMUNOPHARMACOLOGY

Antisense Oligonucleotide Blockade of Tumor Necrosis Factor-α in Two Murine Models of Colitis

Kathleen J. Myers, Sreekant Murthy, Anne Flanigan, Donna R. Witchell, Madeline Butler, Susan Murray, Andrew Siwkowski, Deborah Goodfellow, Karen Madsen and Brenda Baker
Journal of Pharmacology and Experimental Therapeutics January 1, 2003, 304 (1) 411-424; DOI: https://doi.org/10.1124/jpet.102.040329

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleINFLAMMATION AND IMMUNOPHARMACOLOGY

Antisense Oligonucleotide Blockade of Tumor Necrosis Factor-α in Two Murine Models of Colitis

Kathleen J. Myers, Sreekant Murthy, Anne Flanigan, Donna R. Witchell, Madeline Butler, Susan Murray, Andrew Siwkowski, Deborah Goodfellow, Karen Madsen and Brenda Baker
Journal of Pharmacology and Experimental Therapeutics January 1, 2003, 304 (1) 411-424; DOI: https://doi.org/10.1124/jpet.102.040329
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Lipopolysaccharide Induces Epithelium- and Prostaglandin E2-Dependent Relaxation of Mouse Isolated Trachea through Activation of Cyclooxygenase (COX)-1 and COX-2
  • Cannabinoid-Mediated Elevation of Intracellular Calcium: A Structure-Activity Relationship
  • Protease-Activated Receptor-2 Peptides Activate Neurokinin-1 Receptors in the Mouse Isolated Trachea
Show more INFLAMMATION AND IMMUNOPHARMACOLOGY

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics